Zobrazeno 1 - 10 of 54 pro vyhledávání: '"Anders F Mattsson"'
1
Akademický článek
The prevalence of the metabolic syndrome and associated cardiovascular complications in adult-onset GHD during GH replacement: a KIMS analysis
Autor: Johan Verhelst, Anders F Mattsson, Cecilia Camacho-Hübner, Anton Luger, Roger Abs
Publikováno v: Endocrine Connections, Vol 7, Iss 5, Pp 653-662 (2018)
Background: Adult-onset growth hormone deficiency (AO-GHD) is associated with an increased prevalence of the metabolic syndrome (MetS). Aim: To determine the effect of GH replacement on the prevalence of MetS in AO-GHD and to study the impact of Met
Externí odkaz: https://doaj.org/article/b3eec1f075e344ef8ddac874cac8573b
Zobrazit plný text záznamu
2
Pituitary function and the response to GH therapy in patients with Langerhans cell histiocytosis: analysis of the KIMS database
Autor: Philippe Touraine, Yempabou Sagna, Anders F Mattsson, Pia Burman, André P Van Beek, Martin Ove Carlsson, Ferah Aydin, Ulla Feldt-Rasmussen, Cecilia Camacho-Hübner
Publikováno v: European Journal of Endocrinology, 187(3), 373-381. BIOSCIENTIFICA LTD
Touraine, P, Sagna, Y, Mattsson, A F, Burman, P, Van Beek, A P, Carlsson, M O, Aydin, F, Feldt-Rasmussen, U & Camacho-Hübner, C 2022, ' Pituitary function and the response to GH therapy in patients with Langerhans cell histiocytosis : analysis of the KIMS database ', Yosetsu Gakkai Shi/Journal of the Japan Welding Society, vol. 187, no. 3, pp. 373-381 . https://doi.org/10.1530/EJE-22-0160
Objective To analyze the effectiveness and safety of growth hormone (GH) replacement treatment in adult patients with Langerhans cell histiocytosis (LCH) and GH deficiency (GHD) enrolled in KIMS (Pfizer International Metabolic Database). Patients and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6225f47a54f90e4abade919e662fe5c1
https://doi.org/10.1530/eje-22-0160
Zobrazit plný text záznamu
3
Long-Term Safety of Growth Hormone in Adults With Growth Hormone Deficiency
Autor: Gudmundur Johannsson, Philippe Touraine, Ulla Feldt-Rasmussen, Antonio Pico, Greisa Vila, Anders F Mattsson, Martin Carlsson, Márta Korbonits, André P van Beek, Michael P Wajnrajch, Roy Gomez, Kevin C J Yuen
Publikováno v: Johannsson, G, Touraine, P, Feldt-Rasmussen, U, Pico, A, Vila, G, Mattsson, A F, Carlsson, M, Korbonits, M, Van Beek, A C D S P, Wajnrajch, M P, Gomez, R & Yuen, K C J 2022, ' Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency : Overview of 15 809 GH-Treated Patients ', Journal of Clinical Endocrinology and Metabolism, vol. 107, no. 7, pp. 1906-1919 . https://doi.org/10.1210/clinem/dgac199
Journal of Clinical Endocrinology & Metabolism, 107(7), 1906-1919. ENDOCRINE SOC
Context Data on long-term safety of growth hormone (GH) replacement in adults with GH deficiency (GHD) are needed. Objective We aimed to evaluate the safety of GH in the full KIMS (Pfizer International Metabolic Database) cohort. Methods The worldwid
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2e0c2f5c5bb2a30ee98ac5d239f40ca
https://research.rug.nl/en/publications/47c6a976-82cc-4b88-9432-43683ede0c74
Zobrazit plný text záznamu
4
All-cause mortality in patients with acromegaly treated with pegvisomant: an ACROSTUDY analysis
Autor: Camilo Jimenez, Greisa Vila, Anders F Mattsson, Judith Hey-Hadavi, Nicky Kelepouris, Anne Klibanski, Beverly M. K. Biller, Nicholas A. Tritos, Srinivas Rao Valluri
Publikováno v: European Journal of Endocrinology. 182:285-292
Objective To examine all-cause mortality rates in patients with acromegaly on pegvisomant and identify pertinent risk factors, including insulin-like growth factor I (IGF-I). Design Retrospective cohort analysis of data from ACROSTUDY (global surveil
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1745756bc79a4ae6ddf49f96a52fae1
https://doi.org/10.1530/eje-19-0794
Zobrazit plný text záznamu
5
New Neoplasm During GH Replacement in Adults With Pituitary Deficiency Following Malignancy: A KIMS Analysis
Autor: Roger Abs, Katarzyna Krzyzanowska-Mittermayer, Anders F Mattsson, Cecilia Camacho-Hübner, Ulla Feldt-Rasmussen, Dominique Maiter, Anton Luger
Publikováno v: The Journal of Clinical Endocrinology & Metabolism. 103:523-531
Context Data on the association between growth hormone (GH) replacement in patients with GH deficiency (GHD) after malignancies and new neoplasms show conflicting results. Objective To clarify the incidence of new malignant neoplasm in childhood-onse
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dddb38be50f40efee0b3a7bc1d0b2a1a
https://doi.org/10.1210/jc.2017-01899
Zobrazit plný text záznamu
6
Relative Risks of Contributing Factors to Morbidity and Mortality in Adults With Craniopharyngioma on Growth Hormone Replacement
Autor: Eva Marie Erfurth, Cecilia Camacho-Hübner, Kevin C.J. Yuen, Pia Burman, Janet L. Fox, Mitchell E. Geffner, Johan Verhelst, Roger Abs, Anders F. Mattsson
Publikováno v: The Journal of Clinical Endocrinology & Metabolism. 103:768-777
Context In adults, craniopharyngioma (CP) of either childhood-onset (CO-CP) or adult-onset (AO-CP) is associated with increased morbidity and mortality, but data on the relative risks (RRs) of contributing factors are lacking. Objective To assess the
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3038dc0a34a0b5cba2a2c3f68334df9f
https://doi.org/10.1210/jc.2017-01542
Zobrazit plný text záznamu
7
SAT-444 Pituitary Function and the Response to GH Replacement Therapy in Patients with Histiocytosis: Analysis of the Pfizer International Metabolic Database (KIMS)
Autor: Nicky Kelepouris, Anders F Mattsson, Cecilia Camacho-Hübner, Ferah Aydin, Philippe Touraine, André P van Beek, Ulla Feldt-Rasmussen, Pia Burman
Publikováno v: Journal of the Endocrine Society
Introduction: Langerhans Cell Histiocytosis (LCH) is a rare infiltrative disease with granulomatous deposits sometimes involving the hypothalamus-pituitary axis, with endocrine manifestations that includes diabetes insipidus (DI) and growth hormone d
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::329c4c037621f6b799c9625698c4db57
https://doi.org/10.1210/js.2019-sat-444
Zobrazit plný text záznamu
8
Improvements in Body Composition after 4 Years of Growth Hormone Treatment in Adult-Onset Hypopituitarism Compared to Age-Matched Controls
Autor: Christa C. van Bunderen, Cecilia Camacho-Hübner, Mark R Postma, Anders F Mattsson, Peter Jonsson, André P van Beek, Madeleine L. Drent
Publikováno v: Postma, M R, van Beek, A P, Jönsson, P J, van Bunderen, C C, Drent, M L, Mattsson, A F & Camacho-Hubner, C 2019, ' Improvements in Body Composition after 4 Years of Growth Hormone Treatment in Adult-Onset Hypopituitarism Compared to Age-Matched Controls ', Neuroendocrinology, vol. 109, no. 2, pp. 131-140 . https://doi.org/10.1159/000499430
Neuroendocrinology, 109(2), 131-140. KARGER
Neuroendocrinology, 109(2), 131-140. S. Karger AG
Background/Aims: It is unknown whether long-term growth hormone replacement therapy (GHRT) affects body composition in an age- or sex-dependent manner. We aimed to study the effects of 4 years of GHRT on body composition in a large cohort of patients
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cd1d5c2d522c72447312b10f1d305cb
https://research.vumc.nl/en/publications/66612348-25d2-4a7d-9b22-922594bc163d
Zobrazit plný text záznamu
9
Proposal of a clinical response score and predictors of clinical response to 2 years of GH replacement therapy in adult GH deficiency
Autor: Gudmundur Johannsson, Anton Luger, Henri Wallaschofski, Harald Jörn Schneider, Peter H Kann, Anders F Mattsson, Michael Buchfelder
Publikováno v: European Journal of Endocrinology. 173:843-851
ObjectiveThere is no single clinical marker to reliably assess the clinical response to growth hormone replacement therapy (GHRT) in adults with growth hormone deficiency (GHD). The objective of this study was to propose a clinical response score to
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1dde3b07be9a1dab42dd102827fec3d
https://doi.org/10.1530/eje-15-0305
Zobrazit plný text záznamu
10
The prevalence of the metabolic syndrome and associated cardiovascular complications in adult-onset GHD during GH replacement: a KIMS analysis
Autor: Cecilia Camacho-Hübner, Anton Luger, Anders F Mattsson, Roger Abs, Johan Verhelst
Publikováno v: Endocrine Connections
Endocrine Connections, Vol 7, Iss 5, Pp 653-662 (2018)
Background Adult-onset growth hormone deficiency (AO-GHD) is associated with an increased prevalence of the metabolic syndrome (MetS). Aim To determine the effect of GH replacement on the prevalence of MetS in AO-GHD and to study the impact of MetS o
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::188d334d138f38e1435d1f8d5377bcf3
https://pubmed.ncbi.nlm.nih.gov/29661785
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje